Records containing: Primary Biliary Cholangitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-17Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule
-
CLINICAL_TRIALS study record update · 2024-03-13Department of Infectious Diseases, People's Hospital of Xinjiang Uygur Autonomous Region
-
CLINICAL_TRIALS study record update · 2024-02-16Randomized Controlled Trail (RCT) of Emtricitabine, Tenofovir Disoproxil and Raltegravir for Patients With Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid (UDCA)
-
CLINICAL_TRIALS study record update · 2023-11-21[14C]CS0159 in Chinese Healthy Subjects for Mass Balance Phase I Study
-
CLINICAL_TRIALS study record update · 2023-10-10Study Evaluating the Effectiveness of Obeticholic Acid on Hepatic Real-World Outcomes in Patients With Primary Biliary Cholangitis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-06-26Detection Program for Patients With Primary Biliary Cholangitis Lost in the System
-
CLINICAL_TRIALS study record update · 2023-06-07Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis
-
CLINICAL_TRIALS study record update · 2023-05-03A Phase I, Randomized, Double-blind, Placebo-controlled, Single Ascending Does/ Mulelple Ascending Does Study of CS0159 to Evaluate the Safety, Tolerability, Pharmacokynetics, and Food Effect in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2022-05-31A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
-
CLINICAL_TRIALS study record update · 2022-03-24An Open-label, Pilot, Proof of Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Etrasimod (APD334) in Patients With Primary Biliary Cholangitis
-
CLINICAL_TRIALS study record update · 2021-06-22Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Duo to Nonresponse to Standard Therapy
-
CLINICAL_TRIALS study record update · 2021-05-18A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
-
CLINICAL_TRIALS study record update · 2021-03-24A Randomized Controlled Open-label Clinical Trial of Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
-
CLINICAL_TRIALS study record update · 2021-03-22Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II：A Randomized Controlled Open-label Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-10-14A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
-
CLINICAL_TRIALS study record update · 2020-07-08EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study
-
CLINICAL_TRIALS study record update · 2020-01-13A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Biliary Cholangitis Without Cirrhosis
-
CLINICAL_TRIALS study record update · 2019-11-13A Multi-part, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Efficacy of Tropifexor (LJN452) in Patients With Primary Biliary Cholangitis
-
CLINICAL_TRIALS study record update · 2019-03-13The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital
-
CLINICAL_TRIALS study record update · 2019-01-04A Clinical Phase 2 Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
-
CLINICAL_TRIALS study record update · 2018-10-11A Post-Authorisation Non-Interventional Observational, Multi-Site Study of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life (OCARELIFE)
-
CLINICAL_TRIALS study record update · 2018-05-03A Randomized Controlled Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
-
CLINICAL_TRIALS study record update · 2016-03-08The Effect of Bezafibrate on Cholestatic Itch